Join the PROTAC4OncoP53 Project: Help Shape the Future of Precision Cancer Therapy

Are you a motivated and ambitious Master's student looking to contribute to cutting-edge cancer research?

The PROTAC4OncoP53 project is looking for a dedicated and highly motivated student to join our team and contribute to the development of innovative therapeutic strategies targeting mutant p53, one of the most important and challenging targets in cancer biology.

Our project, entitled “Proteolysis-targeting chimeric technology for the development of mutant p53-based anticancer drugs”, explores the potential of PROTAC (Proteolysis-Targeting Chimera) technology to develop new anticancer compounds capable of selectively targeting mutant p53 proteins. By combining innovative medicinal chemistry techniques with cancer research, we aim to advance the discovery of new therapeutic approaches for cancers driven by p53 mutations.

We are looking for someone who is curious, committed, scientifically driven and eager to learn, with the ambition to contribute to high-quality research and to help move promising discoveries from the laboratory towards future therapeutic applications.

What you can expect

Joining the PROTAC4OncoP53 team means becoming part of a research environment focused on:

• Innovative PROTAC-based therapeutic approaches;

• Targeting mutant p53 for cancer treatment;

• Experimental research at the interface of drug discovery, molecular biology and cancer research;

• A collaborative and scientifically stimulating environment;

• The opportunity to contribute to research with potential long-term impact on precision oncology.

If you are a hands-on researcher with scientific curiosity, determination and ambition, and you are excited by the prospect of contributing to the next generation of anticancer strategies, we would be delighted to hear from you.

Research Technician Position

For further information regarding the position, eligibility criteria, application procedure and deadlines, please consult Notice No. TI/1/FARM-ID/2026 for the recruitment and selection of a Research Technician within the framework of the research project:

LISBOA2030-FEDER-00735600 (Project No. 16199)
“Proteolysis-targeting chimeric technology for the development of mutant p53-based anticancer drugs”

The full announcement is available on the FARM-ID website:

View the full recruitment announcement — FARM-ID

Come join us and help turn innovative science into new possibilities for cancer therapy.